SCHEMBL16347343

SCHEMBL16347343

Cc1c[c]nn1Cc1cccc(Br)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
GPR55 Q9Y2T6 1/20 0.46
XDH P47989 1/20 0.45
CYP11B1 P15538 1/20 0.43
ADRA2C P18825 1/20 0.43
CYP11B2 P19099 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
CYP19A1 P11511 3/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
POLB P06746 1/20 0.40
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5095183 0.80 TSHR (0.45) MEN1KMT2ACYP19A1POLBKDM4E
SCHEMBL23003843 0.72 SMN1; SMN2 (0.51) MEN1KMT2ACYP11B1ADRA2CCYP11B2
SCHEMBL28603456 0.70 MGLL (0.39) MEN1KMT2APOLBALDH1A1LMNA
SCHEMBL26307648 0.70 MEN1 (0.62) MEN1KMT2AGPR55SMN1; SMN2CYP19A1
SCHEMBL16344890 0.70 MEN1 (0.49) MEN1KMT2AGPR55XDHCYP11B1
SCHEMBL16347306 0.69 CYP11B1 (0.49) MEN1KMT2AGPR55XDHCYP11B1
SCHEMBL29699803 0.69 PTGER1 (0.69) MEN1KMT2APTGDR2
SCHEMBL16102428 0.65 CYP19A1 (0.59) MEN1KMT2AXDHCYP11B1ADRA2C
SCHEMBL16129815 0.65 CYP11B1 (0.65) XDHCYP11B1ADRA2CCYP11B2SMN1; SMN2
SCHEMBL17731599 0.65 MEN1 (0.48) MEN1KMT2AGPR55XDHCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016934-A2 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME Millennium Pharmaceuticals, Inc. (US) 2016-05-11 EP disclosed
WO-2015002994-A2 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-01-08 WO disclosed